Marshall Wace’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.8M Buy
725,068
+581,575
+405% +$11.3M 0.02% 786
2025
Q4
$3.09M Buy
143,493
+38,380
+37% +$809K ﹤0.01% 1376
2025
Q3
$2.03M Buy
+105,113
New +$1.87M ﹤0.01% 1615
2025
Q2
Sell
-27,197
Closed -$1.74M 3156
2025
Q1
$1.74M Buy
+27,197
New +$2.86M ﹤0.01% 1529
2024
Q4
Sell
-42,938
Closed -$5.36M 3015
2024
Q3
$5.36M Sell
42,938
-397
-0.9% -$54.9K 0.01% 970
2024
Q2
$6.85M Buy
43,335
+39,992
+1,196% +$5.14M 0.01% 878
2024
Q1
$433K Buy
+3,343
New +$410K ﹤0.01% 1988
2023
Q4
Sell
-245,928
Closed -$29.8M 2636
2023
Q3
$29.8M Buy
245,928
+186,886
+317% +$21.1M 0.06% 324
2023
Q2
$6.76M Sell
59,042
-120,217
-67% -$15.5M 0.01% 900
2023
Q1
$24.7M Sell
179,259
-6,746
-4% -$875K 0.06% 390
2022
Q4
$24.1M Buy
+186,005
New +$21.6M 0.06% 397
2022
Q1
Sell
-503,638
Closed -$45.4M 4054
2021
Q4
$45.4M Buy
503,638
+500,289
+14,938% +$42.8M 0.09% 240
2021
Q3
$310K Sell
3,349
-16,170
-83% -$1.25M ﹤0.01% 2633
2021
Q2
$1.52M Sell
19,519
-3,617
-16% -$274K 0.01% 1600
2021
Q1
$1.73M Buy
+23,136
New +$2.13M 0.01% 1395
2019
Q4
Sell
-24,153
Closed -$1.82M 2036
2019
Q3
$1.82M Buy
+24,153
New +$2.85M 0.02% 798
2019
Q2
Sell
-5,967
Closed -$711K 1817
2019
Q1
$711K Sell
5,967
-4,439
-43% -$571K 0.01% 1035
2018
Q4
$1.14M Buy
+10,406
New +$1.3M 0.01% 878
2018
Q3
Sell
-3,667
Closed -$485K 1273
2018
Q2
$485K Sell
3,667
-4,321
-54% -$407K 0.01% 581
2018
Q1
$592K Buy
7,988
+1,845
+30% +$123K 0.02% 331
2017
Q4
$342K Sell
6,143
-21,670
-78% -$1.15M 0.01% 337
2017
Q3
$1.25M Buy
+27,813
New +$1.11M 0.06% 201
2016
Q4
Hold
0
1108
2016
Q3
Hold
0
1125
2015
Q2
Sell
-11,296
Closed -$150K 1036
2015
Q1
$150K Buy
+11,296
New +$151K ﹤0.01% 760

Other funds holding SRPT